S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

KNSA Kiniksa Pharmaceuticals Ltd

19.90

-0.21 (-1.04%)

Last Updated: 11:15:34

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals, Ltd. News

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
Tuesday 7 May 2024 (1 week ago) • GlobeNewswire Inc.

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
Tuesday 23 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
Tuesday 16 April 2024 (1 month ago) • GlobeNewswire Inc.

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 1 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 February 2024 (3 months ago) • Edgar (US Regulatory)

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
Wednesday 28 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Tuesday 27 February 2024 (3 months ago) • Edgar (US Regulatory)

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
Wednesday 21 February 2024 (3 months ago) • GlobeNewswire Inc.

More Kiniksa Pharmaceuticals, Ltd. News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions